Stepan CO 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Stepan Company announced a significant 102% increase in net income for Q2 2026, driven by strong performance in Surfactants and Polymers, alongside a planned workforce reduction of approximately 100 roles.
NYSE
Stepan Company's Annual Meeting on April 28, 2026, saw stockholders vote on director elections, executive compensation, and auditor ratification, with all proposals passing.
NYSE
Stepan Company announced a net loss of $41.4 million for the first quarter of 2026, primarily due to a $65.4 million pre-tax restructuring charge, while adjusted net income fell 47% year-over-year.
NYSE
Stepan Company announces Project Catalyst, a comprehensive operational and efficiency plan targeting $100 million in pre-tax savings over two years through facility closures and asset decommissioning.
NYSE
Stepan Company reported a 49% increase in Q4 reported net income but a 119% decline in adjusted net income, while announcing a major restructuring plan, Project Catalyst, aimed at $100 million in savings.
NYSE
Stepan Company's Board of Directors approved a new Key Executive Severance Benefit Plan, effective November 26, 2025, providing severance compensation and benefits for involuntary terminations.
NYSE
Stepan Company reported a 54% decline in third-quarter net income to $10.8 million, despite a 6% rise in Adjusted EBITDA and a 1% increase in global sales volume, while also declaring its 58th consecutive dividend increase.
NYSE
Samuel S. Hinrichsen, Stepan Company's Global Vice President, Finance and Investor Relations, has resigned effective October 31, 2025.
NYSE
Stepan Company announced a significant increase in second-quarter net income and adjusted EBITDA, driven by Polymer and Crop Productivity growth, despite negative free cash flow and one-time operational costs.
NYSE
Stepan Company announced the appointment of Ruben Velasquez, a seasoned finance executive with over two decades of global experience, as its new Vice President and Chief Financial Officer, effective July 15, 2025.
NYSE
Stepan Company announced the expansion of its Board of Directors to eight members and the immediate appointment of Corning Painter, CEO of Orion S.A., bringing extensive chemical industry leadership and strategic expertise.
NYSE
Stepan Company secures $75 million through the issuance of senior notes to PGIM, Inc. and NYL Investors LLC, maturing in 2033 with a 6.17% interest rate.
NYSE
Stepan Company's stockholders approved the amended and restated 2022 Equity Incentive Compensation Plan at the Annual Meeting on April 29, 2025.
NYSE
Stepan Company's Q1 2025 net income rose 42% year-over-year, driven by growth in surfactants, polymers, and specialty products.
NYSE
Stepan Company has entered into a consulting agreement with its retiring Vice President, General Counsel, and Secretary, David G. Kabbes, to provide transition support.
NYSE
Edward J. Wehmer will retire from Stepan Company's Board of Directors effective at the 2025 Annual Meeting of Stockholders.
NYSE
Stepan Company's Q4 2024 results show a mix of improved net income but a decline in adjusted net income, alongside the announcement of a raised quarterly dividend.
NYSE
Stepan Company announced the retirement of David G. Kabbes, Vice President, General Counsel and Secretary, effective March 14, 2025.
NYSE
Stepan Company has announced a delay in the startup of its new alkoxylation facility in Pasadena, Texas, now expected in the first quarter of 2025 due to unforeseen issues.
NYSE
Stepan Company has amended its previous 8-K filing to include details of the separation agreement with former CEO Scott R. Behrens, effective December 15, 2024.
NYSE
Stepan Company's third quarter results show significant improvements in net income and adjusted EBITDA, driven by strong performance in the Surfactants business, and the company has increased its quarterly dividend.
NYSE
Stepan Company has announced the appointment of Luis E. Rojo as President and Chief Executive Officer, effective immediately, following the departure of Scott R. Behrens.
NYSE
Stepan Company has amended its note purchase agreements, increasing its available borrowing capacity and extending the issuance period.
NYSE
Stepan Company's second quarter 2024 results were impacted by operational issues and a fraud event, though the company saw volume growth and declared a quarterly dividend.
NYSE
Stepan Company held its annual meeting on April 30, 2024, where shareholders elected three directors, approved executive compensation, and ratified the appointment of Deloitte & Touche LLP as the independent auditor for 2024.
NYSE
Stepan Company's first quarter 2024 results show a decrease in net income but an increase in adjusted EBITDA, alongside a declared quarterly dividend of $0.375 per share.
NYSE
Stepan Company reported a net loss for the fourth quarter of 2023, but saw a 3% increase in sales volume and declared a higher dividend.
NYSE
Stepan Company has expanded its Board of Directors by appointing Susan M. Lewis, a seasoned executive with extensive experience in the chemical and agricultural industries.